Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Modeling atopic dermatitis with increasingly complex mouse models.

Scharschmidt TC, Segre JA.

J Invest Dermatol. 2008 May;128(5):1061-4. doi: 10.1038/sj.jid.5701201. Review.

2.

Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models.

Carretero M, Guerrero-Aspizua S, Illera N, Galvez V, Navarro M, García-García F, Dopazo J, Jorcano JL, Larcher F, del Rio M.

J Invest Dermatol. 2016 Jan;136(1):136-45. doi: 10.1038/JID.2015.362.

PMID:
26763433
3.

Skin barrier defects in atopic dermatitis.

Agrawal R, Woodfolk JA.

Curr Allergy Asthma Rep. 2014 May;14(5):433. doi: 10.1007/s11882-014-0433-9.

4.

Cellular and molecular mechanisms in atopic dermatitis.

Oyoshi MK, He R, Kumar L, Yoon J, Geha RS.

Adv Immunol. 2009;102:135-226. doi: 10.1016/S0065-2776(09)01203-6. Review.

PMID:
19477321
5.

Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.

Kaesler S, Volz T, Skabytska Y, Köberle M, Hein U, Chen KM, Guenova E, Wölbing F, Röcken M, Biedermann T.

J Allergy Clin Immunol. 2014 Jul;134(1):92-9. doi: 10.1016/j.jaci.2014.02.017. Epub 2014 Apr 1.

PMID:
24698321
6.

Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.

Suárez-Fariñas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2013 Aug;132(2):361-70. doi: 10.1016/j.jaci.2013.04.046. Epub 2013 Jun 15.

7.

Differential effects of peptidoglycan recognition proteins on experimental atopic and contact dermatitis mediated by Treg and Th17 cells.

Park SY, Gupta D, Kim CH, Dziarski R.

PLoS One. 2011;6(9):e24961. doi: 10.1371/journal.pone.0024961. Epub 2011 Sep 16.

8.

Lessons from murine models of atopic dermatitis.

Zheng T, Zhu Z.

Curr Allergy Asthma Rep. 2005 Jul;5(4):291-7. Review.

PMID:
15967070
9.

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

Boguniewicz M, Leung DY.

Immunol Rev. 2011 Jul;242(1):233-46. doi: 10.1111/j.1600-065X.2011.01027.x. Review.

10.

Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.

Staumont-Sallé D, Abboud G, Brénuchon C, Kanda A, Roumier T, Lavogiez C, Fleury S, Rémy P, Papin JP, Bertrand-Michel J, Tercé F, Staels B, Delaporte E, Capron M, Dombrowicz D.

J Allergy Clin Immunol. 2008 Apr;121(4):962-8.e6. doi: 10.1016/j.jaci.2007.12.1165. Epub 2008 Feb 4.

PMID:
18249437
11.

The potential role of impaired Notch signalling in atopic dermatitis.

Melnik BC.

Acta Derm Venereol. 2015 Jan;95(1):5-11. doi: 10.2340/00015555-1898. Review.

12.

NC/Nga mice: a mouse model for atopic dermatitis.

Suto H, Matsuda H, Mitsuishi K, Hira K, Uchida T, Unno T, Ogawa H, Ra C.

Int Arch Allergy Immunol. 1999;120 Suppl 1:70-5.

PMID:
10529609
13.

A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus.

Kim HJ, Kim YJ, Kang MJ, Seo JH, Kim HY, Jeong SK, Lee SH, Kim JM, Hong SJ.

Exp Dermatol. 2012 Sep;21(9):672-5. doi: 10.1111/j.1600-0625.2012.01539.x. Epub 2012 Jun 29.

PMID:
22742655
14.

CD19 expression in B cells regulates atopic dermatitis in a mouse model.

Yanaba K, Kamata M, Asano Y, Tada Y, Sugaya M, Kadono T, Tedder TF, Sato S.

Am J Pathol. 2013 Jun;182(6):2214-22. doi: 10.1016/j.ajpath.2013.02.042. Epub 2013 Apr 12.

15.

An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases.

Kawakami Y, Yumoto K, Kawakami T.

Allergol Int. 2007 Dec;56(4):403-9. Epub 2007 Sep 1.

16.

The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.

Amano W, Nakajima S, Kunugi H, Numata Y, Kitoh A, Egawa G, Dainichi T, Honda T, Otsuka A, Kimoto Y, Yamamoto Y, Tanimoto A, Matsushita M, Miyachi Y, Kabashima K.

J Allergy Clin Immunol. 2015 Sep;136(3):667-677.e7. doi: 10.1016/j.jaci.2015.03.051. Epub 2015 Jun 24.

PMID:
26115905
17.

Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis.

Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR, Ogawa H, Maibach H, Matsuda H.

Br J Dermatol. 2001 Jan;144(1):12-8.

PMID:
11167677
18.

Molecular basis of atopic dermatitis.

Bonness S, Bieber T.

Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):382-6. Review.

PMID:
17873576
19.

Atopic dermatitis: the role of Langerhans cells in disease pathogenesis.

Dubrac S, Schmuth M, Ebner S.

Immunol Cell Biol. 2010 May-Jun;88(4):400-9. doi: 10.1038/icb.2010.33. Epub 2010 Mar 30. Review.

PMID:
20351749
20.

MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.

Rebane A, Runnel T, Aab A, Maslovskaja J, Rückert B, Zimmermann M, Plaas M, Kärner J, Treis A, Pihlap M, Haljasorg U, Hermann H, Nagy N, Kemeny L, Erm T, Kingo K, Li M, Boldin MP, Akdis CA.

J Allergy Clin Immunol. 2014 Oct;134(4):836-847.e11. doi: 10.1016/j.jaci.2014.05.022. Epub 2014 Jul 2.

PMID:
24996260
Items per page

Supplemental Content

Write to the Help Desk